John Engels - AxoGen Insider

AxoGen Inc -- USA Stock  

USD 28.75  0.25  0.88%

Co-Founder and VP

Mr. John P. Engels is Vice President of AxoGen, Inc., since September 30, 2011. He is a cofounder of AC and has served as ACs Vice President since June 2006, having provided operational and financial leadership and managing AxoGens strategic and product development partnerships until January 2012 when he assumed the leadership of international sales. From 1999 to 2002, Mr. Engels worked as a consultant for the University of Florida, Saffron Hill Ventures and PA Early Stage Partners, among other companies. From 1993 to 1997, Mr. Engels was an analyst and associate at CACM, a boutique investment banking firm. Mr. Engels is currently a member of the board of directors of Oxicool, Inc., a privatelyheld company developing new cooling technologies
Age: 44  Founder Since 2011  MBA    
386-462-6800  http://www.axogeninc.com
Engels holds a MBA in Management and Operations from the Wharton School of Business at the University of Pennsylvania, and a BA from the University of Chicago.

John Engels Latest Insider Activity

John Engels over a month ago via Macroaxis 
AxoGen exotic insider transaction detected

Management Efficiency

The company has return on total asset (ROA) of (15.18) % which means that it has lost $15.18 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (232.9) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 24.38 M in liabilities with Debt to Equity (D/E) ratio of 231.0 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AxoGen Inc has Current Ratio of 3.48 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Entity Summary

AxoGen, Inc. provides surgical solutions for peripheral nerve injuries. The company provides its products to hospitals, surgery centers, and military hospitals in the United States, Canada, the United Kingdom and other European countries, and internationally. AxoGen operates under Medical Appliances Equipment classification in USA and traded on Nasdaq Capital Markets exchange. It employs 138 people.AxoGen Inc (AXGN) is traded on Nasdaq Capital Markets in USA. It is located in FLORIDA, U.S.A and employs 138 people. AxoGen is listed under Medical Equipment category by Fama And French industry classification.

Did you try this?

Run Correlation Analysis Now
   

Correlation Analysis

Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Hide  View All  NextLaunch Correlation Analysis
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add AxoGen Inc to your portfolio

Top Management

AxoGen Inc Leadership Team
Robert Rudelius, Director
Peter Mariani, CFO
Mark Friedman, President
John Engels, Founder, MBA
Jamie Grooms, Chairman
Shawn McCarrey, SVP
Amy Wendell, Director
Kevin Leach, President
Joseph Mandato, Director
Mike Donovan, Director, MBA
Erick DeVinney, President
Karen Zaderej, CEO, MBA
Gregory Freitag, President
David Hansen, Executive
Guido Neels, Director
Jon Gingrich, Executive
Mark Gold, Director
James Grooms, Chairman

Stock Performance

AxoGen Performance Indicators